Skip to main content

Table 1 The role of important immune cells that involve in kidney disease

From: The immune regulatory role of lymphangiogenesis in kidney disease

 

Acute kidney injury

Kidney fibrosis

Hypertensive nephropathy

Diabetic kidney disease

IgA glomerulonephritis

Lupus nephritis

Polycystic kidney disease

Kidney transplantation (allograft rejection)

Immune cells

        

Macrophage

Macrophages can induce kidney lymphangiogenesis through upregulated expression level of VEGF-C and can also directly promote lymphangiogenesis through transdifferentiating into LECs[43, 114, 116]

 

M1 macrophages enhance lymphangiogenesis and promote kidney inflammation response, aggravating kidney injury[51, 53]

M2 macrophages promote tissue fibrosis process in the context of chronic kidney disease and kidney fibrosis [53]

Macrophages aggravate kidney damage and elevating blood pressure level. Meanwhile, hypertensive condition activates TonEBP in VEGF-C-expressing macrophages, leading to expression of VEGF-C, which promotes lymphangiogenesis, subsequently enhancing removal of excessive interstitial fluid [102]

M1 macrophages are the predominant macrophages within DKD, which enhance the inflammation response through secreting pro-inflammatory cytokines and presenting antigens to initiate immune response, ultimately causing renal injury. M2 macrophages can suppress the immune response within DKD through expressing anti-inflammatory cytokines [155,156,157]

CD137L-secreted macrophages interact with CD137 on LECs, inducing lymphatics autophagy and lymphangiogenesis [140]

M2 macrophages promote tissue fibrosis process in the context of chronic kidney disease and kidney fibrosis [53]

M2 macrophages are predominant macrophage within PKD. They promote the growing of cysts [144]

 

Cytotoxic T cell

Activated CD8 + T cells directly promote immune response at injury site. In contrast, infiltrated CD8 + T cells can induce LECs to produce PD-L1, further suppressing local CD8 + T cell [67]

  

IFN-γ-producing CD8 + T cells inhibit the differentiation of CD4 + T cell into Th2 cells, subsequently control kidney inflammation and fibrosis [88, 89]

CD11c + CD8 + T cells induce fibroblast apoptosis in obstructed kidney disease [88, 89]

    

CD8+ T cells present a protective role in the context of PKD [146]

 

Th cell

Th17 cells recruits neutrophils and other inflammatory cells to significantly aggravates kidney tissue damage and accelerates the progression to CKD [65, 66]

Th17 cells and Th2 cells present a profibrotic effect on injured site [86, 87]

Th1 cells and T17 cells secrete pro-inflammatory and pro-hypertensive cytokines, ultimately causing kidney tissue damage and sodium retention [110]

Th17 and Th1 cells conduct a strong pro-inflammatory response within DKD. Th 2 cells mainly suppress Th1 activation and therefore the inflammatory response, ameliorating the progression of kidney fibrosis [87, 158]

The distinct polarization patterns of Th1, Th2, and Th17 cells within IgAN lead to abnormalities of lymphocyte function. However, the differentiation of Th17 might improve the abnormal humoral immunity[137,138,139]

  

Th1/Th2 balance predominantly regulates transplant rejection [131]

Treg cell

Treg cells inhibit immune response by secreting suppressive cytokines and direct communication between cells. During AKI, T reg cells inhibit inflammation and facilitate tissue repair to reduce renal injury [72]

Treg cells protect the kidney against fibrosis progress [85]

Treg cells alleviate kidney inflammation response and improve sodium retention [72, 111]

Treg cells improve insulin resistance and suppress the immune response in kidney to ameliorate DN pathogenesis within the hyperglycemia setting [112]

Treg cells elicit attenuated immunosuppressive function within IgAN [159]

  

Treg cells mediate between transplant tolerance and rejection [160]

B cell

 

Recruitment of B cells in renal tissue exacerbates kidney fibrosis via increasing macrophage infiltration [82], inhibiting T cell differentiation and activation [83, 84]

  

Abnormally-functioned B cells exert a pathophysiological role within IgAN [133], [161]

  

B cells are crucial both in T cell-mediated graft rejection and antibody-mediated graft rejection [162]

Dendritic cell

CCR7 + dendritic cells at injury site dispose antigens and then present these antigens to CD8 + T cells in kidney draining lymph node, activating the activation and homing of antigen-specific CD8 + T cells. During AKI, dendritic cells contribute to a positive feedback that aggregates inflammation response [48, 57, 71, 72]